Doe v. ObamaDoe v. Obama
MEMORANDUM OPINION
Before this Court is a Motion to Dismiss filed on behalf of Defendants, Barack Obama, in his official capacity as President of the United States; Charles E.
Johnson
1
,
in his official capacity as Acting Secretary of the Department of Health and Human Services (“HHS”); and Raynard S. Kingston
2
, in his official capacity as Acting Director of the National Institutes of Health (“NIH”) (collectively referred to as the “Government”). (Doc. No. 10.) Plaintiffs Mary Scott Doe, a human embryo frozen in cyro-preservation within the United States on behalf of herself and those similarly situated; National Organization for Embryonic Law (“NOEL”), a non-profit organization pursuing the legal protection of human life;
3
and four married couples
4
who are putative adopters of human embryos bring this complaint seeking declaratory and injunctive relief against the Defendants.
5
The Plaintiffs claim that President Obama’s Executive Order 13505 issued on March 9, 2009,
FACTUAL BACKGROUND
This ease involves highly controversial issues concerning the morality of federally funded stem cell research on human embryos. At the heart of this controversy is one method used by researchers to derive a stem cell line or source from human embryos through a process that necessitates the destruction of the human embryos. Although some believe that embryo stem cell research has the potential for developing cures to numerous diseases, others believe that the destruction of human embryos in the extraction process equates to killing human life, which the Government should not use tax dollars to support. In 1996, Congress passed the Dickey-Wicker Amendment, which is an appropriations bill that prohibits the HHS and NIH from using federal funds in either “(1) the creation of human embryos for research purposes,” or (2) “for research in which human embryos are destroyed, discarded, or knowingly subjected to risk of injury or death greater than that allowed on fetuses in útero.... ” Omnibus Appropriations Act, 2009, Pub. L. No. Ill— 8, Division F, Title V, § 509(a), 123 Stat. 524, 803 (2009).
Former President George W. Bush issued a statement on August 9, 2001, in which he permitted federal funding for research on stem cell lines from “embryos that have already been destroyed” and were derived by private or foreign researchers. George W. Bush, Former President of the United States, Presidential Address: Address to the Nation on Stem Cell Research from Crawford, Texas, 37 Weekly Comp. Pres. Doc. 32, 1149-51 (August 9, 2001), available at http://www. gpoaccess.gov/index.html (follow “Presidential Materials” hyperlink; then follow “Weekly Compilation of Presidential Documents”; then follow “2001” hyperlink; then follow “August 13, 2001” hyperlink). In his statement, Bush explained that his policy was an attempt to balance the potential benefits of stem cell research, such as improving the lives of those suffering from “juvenile diabetes ... Alzheimer’s ... Parkinson’s ... and spinal cord injuries,” and the moral and ethical concerns raised in opposition to stem cell research. Id. at 1149. To this end, Bush issued Executive Order 13435 on June 20, 2007, which reinforced his ban on federally funded research on stem cell lines created after August 9, 2001, and encouraged research into non-embryonic sources of stem cell research.
On March 9, 2009, President Obama issued Executive Order 13505 entitled, “Removing Barriers to Responsible Scientific Research Involving Human Stem Cells,” which removed prior Presidential limitations on stem cell research and permitted the NIH to “support and conduct responsible ... research, including human embryonic stem cell research, to the extent permitted by law.” Exec. Order No. 13,-505, 74 Fed. Reg. 10667 (March 9, 2009). Specifically, Obama’s Executive Order revoked Bush’s Executive Order 13435 and explained that Bush’s August 9 statement was no longer effective as a statement of
Plaintiffs’ complaint requests that this Court invalidate Executive Order 13505 and enjoin its implementation because it allows for federal funding of stem cell research that destroys human embryos in violation of the Dickey-Wicker Amendment and violates the embryos’ constitutional rights to due process and equal protection guaranteed under the Fifth and Fourteenth Amendments and to freedom from slavery and involuntary servitude guaranteed under the Thirteenth Amendment.
STANDARD OF REVIEW
Pursuant to Rule 12(b)(1) of the Federal Rules of Civil Procedure, federal courts must dismiss claims where the court lacks subject-matter jurisdiction. Although courts are permitted to consider materials outside of the pleadings to determine whether it can exercise subject-matter jurisdiction, the court must generally accept as true all factual allegations pled in the complaint.
Albright v. Oliver,
Plaintiffs bringing claims in federal court must meet the requirements of standing in order for the court to exercise subject-matter jurisdiction.
Lujan v. Defenders of Wildlife,
In addition to establishing the constitutional requirements of standing, plaintiffs must also demonstrate that their claims can survive prudential limitations to the federal court’s exercise of jurisdiction.
Elk Grove Unified Sch. Dist. v. Newdow,
The Defendants argue that even if the Court were to find that Plaintiffs meet the requirements of standing, their claims should be dismissed pursuant to Rule 12(b)(6) for failure to state a claim upon which relief could be granted. Because this Court agrees with Defendants, and finds that all Plaintiffs lack standing, the Court dismisses the compliant without needing to address the merits of the substantive claims.
I. Standing
A. Embryos
The complaint names “Mary Doe,” an unspecified embryo frozen in a state of “cyro-preservation” in some undetermined location within the United States as a Plaintiff in this action, and asserts that Mary Doe, along with nearly 20,000 other embryos, are “human beings” who will suffer an imminent threat of destruction or involuntary servitude if federal funding for stem cell research on human embryos is permitted. The so-called embryo Plaintiffs argue in their opposition that the standard for a motion to dismiss requires this Court to presume as true their “factual” allegation that embryos are “human beings.” However, as the Defendants argue, the Supreme Court’s decision in
Ashcroft v. Iqbal,
makes clear that “the tenant that a court must accept as true all of the allegations contained in a complaint is inapplicable to legal conclusions.” — U.S. —,
The Supreme Court has already determined that the word “person [as used] in the Fourteenth Amendment does not include the unborn.”
Roe v. Wade,
Moreover, in dismissing a claim asserted by an unspecified embryo seeking to enjoin the NIH from submitting a report to the HHS on human fetal tissue research, this Court in
Doe v. Shalala
declined to appoint a guardian ad litem to the embryos because “embryos are not persons with legally protectable interests ...”
B. NOEL
The complaint alleges that NOEL is entitled to declaratory and other necessary relief because “its purpose is a constitutional legal challenge to establish the equal humanity of preborn children beginning as human embryos.” (Compl. ¶80.) However, the Plaintiffs’ opposition to the Motion to Dismiss fails to address how NOEL has standing to bring this claim. In any event, organizations must establish standing by either bringing claims to assert the rights of the organization itself or to litigate claims on behalf of its members.
Buchanan v. Consol. Stores Corp.,
The complaint does not allege any injury suffered by the members of NOEL, and thus NOEL appears to be bringing a claim to assert the organizations’ rights. To the extent that the complaint alleges that NOEL suffers an injury because it is unable to fulfill its purpose of bringing legal challenges in the hopes of establishing “equal humanity of preborn children,” the Court does not find this injury sufficient to meet the requirements of standing. First, as Defendants note, NOEL is fulfilling its purpose of pursuing constitutional challenges by the very act of filing this lawsuit. Moreover, as pointed out by Defendants, this Court has already ruled that a mere “conflict between a defendant’s conduct and [an] organization’s mission is alone insufficient to establish Article III standing.”
Buchanan,
C. Adoptive parents
The putative adoptive parents allege that they have children whom they adopted in vitro and are “considering the adoption of and/or seeking to adopt in vitro human embryos,” and assert that Defendants’ actions will “necessarily reduce the number of in vitro human embryos available for adoption.” (Compl. ¶ 82.) Although it is arguable from the complaint whether the potential adoptive parents have concrete plans to adopt an embryo, for the purposes of a motion to dismiss, the Court must infer this allegation in favor of the Plaintiffs. However, the guidelines proposed by NIH to implement Executive Order 13505 restrict federal funding to embryos donated for research purposes after the donors of the unused embryos no longer need the embryos for reproduction. Moreover, the draft guidelines specifically require the donors to be informed of all their options concerning their unused embryos and seek to create precautions to ensure that donors are not influenced into choosing donation for research over other options such as storage for later use, adoption, or disposal. Thus, it is the donor’s choice which could potentially reduce the number of human embryos for adoption and not the Defendants’ conduct which “causes” Plaintiffs’ alleged injury. Accordingly, the Court concludes that the adoptive parent Plaintiffs lack Article III standing to assert any claim alleged in the complaint.
Moreover, the Court notes that the adoptive parent Plaintiffs cannot overcome the prudential limitations to standing. First, given the hypothetical nature of these unspecified embryos the Court finds that the Plaintiffs do not stand in a sufficiently close relationship to the embryos to bring a claim on their behalf. In any event, the embryos must themselves have standing on their own for the adoptive parents to represent their claims, and as discussed above, embryos lack such standing. Moreover, the adoptive parents argue that “as federal taxpayers who are morally opposed to destructive stem cell research, [they] clearly fall within the zone of interest that the Dickey-Wicker Amendment seeks to protect,” which they
CONCLUSION
For the foregoing reasons, the Court holds that all of the presented Plaintiffs lack standing to assert the rights and claims alleged in the complaint. Therefore, the Court GRANTS Defendants’ Motion to Dismiss (Doc. No. 10). A separate order shall follow this Memorandum Opinion.
Notes
. Pursuant to Fed.R.Civ.P. 25(d), Kathleen Sebelius, as the confirmed successor to HHS's former Acting Secretary, Charles E. Johnson, is automatically substituted as the proper party defendant in this action.
. Likewise, Dr. Francis S. Collins, as the confirmed successor to NIH’s former Acting Secretary, Raynard S. Kingston, is automatically substituted as the proper party defendant in this action.
. The complaint states that NOEL's "primary mission is to protect, support, educate, and pursue the legal protection of human life from its beginning at conception until after death.” (Compl. ¶ 5.)
. Namely the couples are Peter and Suzanne Murray, Courtney and Tim Atnip, Steven and Kate Johnson, and Cora and Gregory Vest.
. The complaint originally included Nightlight Christian Adoptions ("Nighlight”), "which is a licensed adoption agency ... and operates a program known as the Snowflake Frozen Embryo Adoption program that offers families who had frozen embryos brought into being by in vitro fertilization the opportunity to place those embryos for adoption by qualified parents.” According to Plaintiffs' Motion for Leave to File an Amended Complaint, Nightlight no longer wishes to remain a party in this litigation and the Court will grant that motion in a separate order.
. Since the filing of the briefs on this motion, NIH issued final guidelines relating to federally funded human embryo stem cell research.